Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) — via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI)…
News
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) — via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI)…
First Wave BioPharma To Present at the BIO Investor Forum
BOCA RATON, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First…
First Wave BioPharma To Present at the BIO Investor Forum
BOCA RATON, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First…
Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
Executive with three decades of successful multinational operations and commercial experience to lead launch of…
Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
Executive with three decades of successful multinational operations and commercial experience to lead launch of…
CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference
NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical…
CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference
NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical…
Jasper Therapeutics to Present at the Cantor Fitzgerald 2023 Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper),…
Jasper Therapeutics to Present at the Cantor Fitzgerald 2023 Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper),…
Ascendis Pharma Launches SKYTROFA® (lonapegsomatropin) in Germany for the Once-Weekly Treatment of Children and Adolescents with Growth Hormone Deficiency
COPENHAGEN, Denmark, Sept. 15, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
Ascendis Pharma Launches SKYTROFA® (lonapegsomatropin) in Germany for the Once-Weekly Treatment of Children and Adolescents with Growth Hormone Deficiency
COPENHAGEN, Denmark, Sept. 15, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Vivoryon Therapeutics N.V. Extraordinary General Meeting Approved Appointment of New Executive Directors to the Board
Vivoryon Therapeutics N.V. Extraordinary General MeetingApproved Appointment of New Executive Directors to the Board Halle…
Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Vivoryon Therapeutics N.V. Extraordinary General Meeting Approved Appointment of New Executive Directors to the Board
Vivoryon Therapeutics N.V. Extraordinary General MeetingApproved Appointment of New Executive Directors to the Board Halle…
Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP),…
Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP),…
OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
LONDON and NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO)…
OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
LONDON and NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO)…